Machine learning and statistical prediction of overall survival (OS) from pre-dose plasma biomarkers in a randomized phase 2 trial (1801 Part 3B) of the GSK-3 inhibitor elraglusib in metastatic ...
Identification of differential epigenetic landscapes in subtypes of appendiceal cancer. A multiregional, randomized, controlled, open-label, phase 3 study of the anti-claudin18.2 (CLDN18.2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results